KX-826 , a small change in the pipeline
    Research/Science 2/10/2026

    At a glance
    In this research discussion post, the primary subjects mentioned are
    πŸ’§ KX-826 (topical) 0.5% and 1.0% BID
    πŸ’§ Clascoterone (topical)
    πŸ’§ Minoxidil (topical) 5% 2x daily 5 weeks
    πŸ’§ Dermarolling (topical) 1x weekly
    the tone is 😐 neutral with modest improvements results.

    Other terms

    KX-826 is undergoing trials for hair loss treatment, showing similar effectiveness between 0.5% and 1.0% dosages, with mild side effects compared to finasteride. Users discuss combining KX-826 with other treatments like minoxidil and clascoterone for better results.
    View this post in the Community β†’

    Similar Community Posts Join

    5 / 430 results

      community KX-826 Pyrilutamide1% coming soon

      in Update  152 upvotes 1 year ago
      KX-826 Pyrilutamide 1% is launching soon, and users are discussing its potential benefits and drawbacks compared to other treatments like Minoxidil and finasteride. Some users are skeptical about its effectiveness, while others are hopeful it will be a safer alternative.

      community When could we expect pp405 to hit the market?

      in Research/Science  31 upvotes 10 months ago
      PP405 is expected to finish Phase 2 trials in late 2025, with potential market availability around 2028-2029 if all goes well. Current treatments like finasteride and minoxidil are still popular, while new options like KX-826 and Breezula are anticipated soon.

      community When is the cure gonna drop , how much more time

      in Research/Science  112 upvotes 1 month ago
      There is no imminent cure for hair loss, but treatments like Minoxidil, Finasteride, and new drugs such as KX-826, GT-20029, and PP405 are being explored. Current solutions focus on slowing hair loss and stimulating growth, with hopes for better options in the future.

    Related Research

    6 / 178 results